Search Results - "HADENGUE, A"

Expression of NOXI, a superoxide-generating NADPH oxidase, in colon cancer and inflammatory bowel disease by SZANTO, I, RUBBIA-BRANDT, L, KISS, P, STEGER, K, BANFI, B, KOVARI, E, HERRMANN, F, HADENGUE, A, KRAUSE, K.-H

Get full text

Expression of NOX1, a superoxide-generating NADPH oxidase, in colon cancer and inflammatory bowel disease by Szanto, I, Rubbia-Brandt, L, Kiss, P, Steger, K, Banfi, B, Kovari, E, Herrmann, F, Hadengue, A, Krause, K-H

“…Reactive oxygen species (ROS) are at the centre of many physiological and pathological processes. NOX1, a ROS‐producing NADPH oxidase, is highly expressed in…”
Get full text

Hepatopulmonary Syndrome Increases the Postoperative Mortality Rate Following Liver Transplantation: A Prospective Study in 90 Patients by Schiffer, E., Majno, P., Mentha, G., Giostra, E., Burri, H., Klopfenstein, C. E., Beaussier, M., Morel, P., Hadengue, A., Pastor, C. M.

“…Hepatopulmonary syndrome (HPS) is a frequent pulmonary complication of patients with end‐stage liver diseases. HPS is diagnosed by hypoxemia and pulmonary…”
Get full text

Long-term hepatitis E viral load kinetics in an immunocompromised patient treated with ribavirin by Ambrosioni, J., Mamin, A., Hadengue, A., Bernimoulin, M., Samii, K., Landelle, C., Negro, F., Kaiser, L.

“…Hepatitis E virus (HEV) can cause chronic infections in immunocompromised hosts. Viral kinetics in plasma and stools are poorly understood, particularly during…”
Get full text

Peroxisome proliferator‐activated receptor‐α and ‐γ mRNA levels are reduced in chronic hepatitis C with steatosis and genotype 3 infection by DE GOTTARDI, A., PAZIENZA, V., PUGNALE, P., BRUTTIN, F., RUBBIA‐BRANDT, L., JUGE‐AUBRY, C. E., MEIER, C. A., HADENGUE, A., NEGRO, F.

“…Summary Background Steatosis in chronic hepatitis C is associated with inflammation and accelerated fibrogenesis. Aim To assess the contribution of peroxisome…”
Get full text

FOLFOX4 versus sequential dose-dense FOLFOX7 followed by FOLFIRI in patients with resectable metastatic colorectal cancer (MIROX): a pragmatic approach to chemotherapy timing with perioperative or postoperative chemotherapy from an open-label, randomized phase III trial by Hebbar, M., Chibaudel, B., André, T., Mineur, L., Smith, D., Louvet, C., Dutel, J.L., Ychou, M., Legoux, J.L., Mabro, M., Faroux, R., Auby, D., Brusquant, D., Khalil, A., Truant, S., Hadengue, A., Dalban, C., Gayet, B., Paye, F., Pruvot, F.R., Bonnetain, F., Taieb, J., Brucker, P., Landi, B., Flesch, M., Carola, E., Martin, P., Vaillant, E., de Gramont, A.

“…The sequential FOLFOX7–FOLFIRI combination is not superior to FOLFOX4 in colorectal cancer patients with resectable metastases. Patients with synchronous…”
Get full text

Combination of steroids with infliximab or placebo in severe alcoholic hepatitis: a randomized controlled pilot study by Spahr, Laurent, Rubbia-Brandt, Laura, Frossard, Jean-Louis, Giostra, Emile, Rougemont, Anne-Laure, Pugin, Jérôme, Fischer, Maria, Egger, Hanspeter, Hadengue, Antoine

“…Background/Aims: The aim of this study is to evaluate the tolerance and effects of infliximab combined with steroids in severe alcoholic hepatitis (AH)…”
Get full text

2352 Sunitinib as second-line treatment in patients with advanced intrahepatic cholangiocarcinoma: Final results of the SUN-CK phase II trial from GERCOR IRC by Neuzillet, C, Seitz, J.F, Fartoux, L, Malka, D, Lledo, G, Tijeras-Raballand, A, De Gramont, A, Ronot, M, Bouattour, M, Dreyer, C, Granier, M, Benner, S, Amin, A, Bourget, P, Hadengue, A, Roldan, N, Chibaudel, B, Raymond, E, Faivre, S

Get full text

FOLFOX4 versus sequential dose-dense FOLFOX7 followed by FOLFIRI in patients with resectable metastatic colorectal cancer (MIROX): a pragmatic approach to chemotherapy timing with perioperative or postoperative chemotherapy from an open-label, randomized phase III trial by Hebbar, M., Chibaudel, B., André, T., Mineur, L., Smith, D., Louvet, C., Dutel, J.L., Ychou, M., Legoux, J.L., Mabro, M., Faroux, R., Auby, D., Brusquant, D., Khalil, A., Truant, S., Hadengue, A., Dalban, C., Gayet, B., Paye, F., Pruvot, F.R., Bonnetain, F., de Gramont, A.

Get full text

New serum markers for the detection of severe acute pancreatitis in humans by FROSSARD, Jean-Louis, HADENGUE, Antoine, PASTOR, Catherine M

Get full text

Low‐dose oral microemulsion ciclosporin for severe, refractory ulcerative colitis by SAUSSURE, P., SORAVIA, C., MOREL, P., HADENGUE, A.

“…Summary Background:  The optimal modalities of treatment with oral microemulsion ciclosporin in patients with severe, steroid‐refractory ulcerative colitis are…”
Get full text

The role of junctional adhesion molecule C (JAM-C) in acute pancreatitis by Vonlaufen, A, Aurrand-Lions, M, Pastor, CM, Lamagna, C, Hadengue, A, Imhof, BA, Frossard, J-L

“…The recruitment of inflammatory cells contributes significantly to tissue injury in acute pancreatitis. This process implies several molecular interactions…”
Get full text

Is TIPS really superior to endoscopic therapy in the prevention of rebleeding from gastric varices? by Spahr, L, Maffei, M, Hadengue, A

Get more information

Impact of Treatment with Human Immunodeficiency Virus (HIV) Protease Inhibitors on Hepatitis C Viremia in Patients Coinfected with HIV by Rutschmann, O. T., Negro, F., Hirschel, B., Hadengue, A., Anwar, D., Perrin, L. H.

“…The impact of human immunodeficiency virus (HIV) protease inhibitors on hepatitis C (HCV) viremia was assessed in 19 patients infected with both HIV and HCV…”
Get full text

6144 POSTER Phase II Study of Panitumumab With Irinotecan for Patients With KRas Wild-type Metastatic Colorectal Cancer (MCRC) Refractory to Standard Chemotherapy – a GERCor Study by Andre, T, Chibaudel, B, Mabro, M, Bennamoun, M, Artru, P, Bachet, J.B, Hadengue, A, Blons, H, Laurent-Puig, P, de Gramont, A

Get full text

184 RISK OF COMPLICATIONS AFTER ABDOMINAL PARACENTESIS IN CIRRHOTIC PATIENTS: A PROSPECTIVE STUDY by De Gottardi, A, Thévenot, T, Spahr, L, Morard, I, Bresson-Hadni, S, Torres, F, Giostra, E, Hadengue, A

Get full text

A Case of Drug-Induced Hepatitis due to Lenalidomide by Zanella, M.-C., Rubbia-Brandt, L., Giostra, E., Chalandon, Y., Hadengue, A., Spahr, L.

“…Lenalidomide is a recent thalidomide analog used for the treatment of refractory multiple myeloma. The main toxicity of this drug consists in severe…”
Get full text

Tezosentan normalizes hepatomesenteric perfusion in a porcine model of cardiac tamponade by ÅNEMAN, A., TREGGIARI, M. M., BURGENER, D., LAESSER, M., STRASSER, S., HADENGUE, A.

“…Background: To investigate endothelin‐1 (ET‐1)‐dependent hepatic and mesenteric vasoconstriction, and oxygen and lactate fluxes in an acute, fixed low cardiac…”
Get full text

60 LIVER STEATOSIS AND NAFLD AFTER LIVER TRANSPLANTATION: A STUDY ON PREVALENCE AND RISK-FACTORS by Dumortier, J, Giostra, E, Guillaud, O, Belbouab, S, Morard, I, Spahr, L, Boillot, O, Rubbia-Brandt, L, Scoazec, J.-Y, Hadengue, A

Get full text

In vivo microscopic examination of the esophagus for the detection of cancer before liver transplantation in patients with alcoholic cirrhosis by Dumonceau, J M, Giostra, E, Genta, R, Mentha, G, Rubbia-Brandt, L, Hadengue, A

“…Esophageal squamous-cell carcinoma is relatively common in alcohol and tobacco abusers, and it can develop rapidly after liver transplantation. We report the…”
Get more information